StockData
Phathom Pharmaceuticals, Inc. logo

Phathom Pharmaceuticals, Inc. (PHAT) income statement

PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/30
$4.66−0.42 (-8.27%)

Close on Nov 20, 2026Market cap $378.82MP/E –Yield –

Phathom Pharmaceuticals, Inc. financial ratios

See a number that looks wrong?